Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.660
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
0.650
-0.010 (-1.52%)
After-hours: Apr 28, 2026, 7:19 PM EDT
Impact BioMedical Employees
Impact BioMedical had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$16,000
Profits / Employee
-$5,919,000
Market Cap
71.16M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 142 |
| Fortress Biotech | 78 |
| Acrivon Therapeutics | 76 |
| ImmuCell | 73 |
| OnKure Therapeutics | 45 |
| BeyondSpring | 44 |
| Actuate Therapeutics | 12 |
| MediciNova | 6 |
IBO News
- 25 days ago - Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans - GlobeNewsWire
- 9 months ago - Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue - GlobeNewsWire
- 11 months ago - Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger - GlobeNewsWire
- 1 year ago - Impact Biomedical Inc. Announcement Stock Activity/Pricing - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. to Present at The Microcap Conference - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue - GlobeNewsWire